NasdaqCM - Delayed Quote USD

Biomerica, Inc. (BMRA)

0.7130 -0.0090 (-1.25%)
At close: April 24 at 4:00 PM EDT
0.7140 +0.00 (+0.14%)
After hours: April 24 at 6:41 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
5/31/2023
5/31/2022
5/31/2021
5/31/2020
Total Revenue
5,407.0000
5,339.0000
18,871.0000
7,199.0270
6,692.7110
Cost of Revenue
4,787.0000
4,893.0000
15,894.0000
6,832.7420
4,954.4840
Gross Profit
620.0000
446.0000
2,977.0000
366.2850
1,738.2270
Operating Expense
7,295.0000
7,669.0000
7,511.0000
7,865.9780
4,479.1920
Operating Income
-6,675.0000
-7,223.0000
-4,534.0000
-7,499.6930
-2,740.9650
Net Non Operating Interest Income Expense
373.0000
133.0000
27.0000
66.4960
71.1840
Other Income Expense
--
1.0000
--
66.8630
71.1930
Pretax Income
-6,301.0000
-7,089.0000
-4,507.0000
-7,433.1970
-2,669.7810
Tax Provision
48.0000
51.0000
24.0000
13.0570
7.3900
Net Income Common Stockholders
-6,349.0000
-7,140.0000
-4,531.0000
-7,446.2540
-2,677.1710
Diluted NI Available to Com Stockholders
-6,349.0000
-7,140.0000
-4,531.0000
-7,446.2540
-2,677.1710
Basic EPS
-0.37
-0.50
-0.36
-0.62
-0.26
Diluted EPS
-0.37
-0.50
-0.36
-0.62
-0.26
Basic Average Shares
16,764.7540
14,154.2690
12,673.2450
11,928.9410
10,166.2960
Diluted Average Shares
16,764.7540
14,154.2690
12,673.2450
11,928.9410
10,166.2960
Total Operating Income as Reported
-6,675.0000
-7,223.0000
-4,534.0000
-7,499.6930
-2,740.9650
Total Expenses
12,082.0000
12,562.0000
23,405.0000
14,698.7200
9,433.6760
Net Income from Continuing & Discontinued Operation
-6,349.0000
-7,140.0000
-4,531.0000
-7,446.2540
-2,677.1710
Normalized Income
-6,349.0000
-7,140.0000
-4,531.0000
-7,446.2540
-2,677.1710
Interest Income
373.0000
133.0000
27.0000
66.8630
71.1930
Interest Expense
--
--
--
0.3670
0.0090
Net Interest Income
373.0000
133.0000
27.0000
66.4960
71.1840
EBIT
-6,675.0000
-7,223.0000
-4,534.0000
-7,432.8300
-2,669.7720
EBITDA
-6,315.0000
-6,872.0000
-3,939.0000
-7,056.9750
-2,271.1400
Reconciled Cost of Revenue
4,787.0000
4,893.0000
15,894.0000
6,832.7420
4,954.4840
Reconciled Depreciation
360.0000
351.0000
595.0000
375.8550
398.6320
Net Income from Continuing Operation Net Minority Interest
-6,349.0000
-7,140.0000
-4,531.0000
-7,446.2540
-2,677.1710
Total Unusual Items Excluding Goodwill
--
--
--
66.8630
71.1930
Total Unusual Items
--
--
--
66.8630
71.1930
Normalized EBITDA
-6,315.0000
-6,872.0000
-3,939.0000
-7,056.9750
-2,271.1400
Tax Rate for Calcs
0.0004
0.0002
0.0002
0.0003
0.0003
5/31/2020 - 9/7/1984

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

QTI QT Imaging Holdings, Inc.
0.8737
-1.28%
 
MOVE Movano Inc.
0.4990
+2.46%
 
AXDX Accelerate Diagnostics, Inc.
0.9310
-2.00%
 
RTSL Rapid Therapeutic Science Laboratories, Inc.
0.0050
0.00%
 
AEMD Aethlon Medical, Inc.
1.5300
0.00%
 
NMTC NeuroOne Medical Technologies Corporation
1.1600
+1.75%
 
OSAP ProSomnus, Inc.
0.1599
-5.97%
 
NURO NeuroMetrix, Inc.
4.3300
-5.04%
 
MYO Myomo, Inc.
3.4400
-2.82%
 
SNWV SANUWAVE Health, Inc.
0.0230
+4.55%